Recent Development of Non-Peptide GnRH Antagonists
AbstractThe decapeptide gonadotropin-releasing hormone, also referred to as luteinizing hormone-releasing hormone with the sequence (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) plays an important role in regulating the reproductive system. It stimulates differential release of the gonadotropins FSH and LH from pituitary tissue. To date, treatment of hormone-dependent diseases targeting the GnRH receptor, including peptide GnRH agonist and antagonists are now available on the market. The inherited issues associate with peptide agonists and antagonists have however, led to significant interest in developing orally active, small molecule, non-peptide antagonists. In this review, we will summarize all developed small molecule GnRH antagonists along with the most recent clinical data and therapeutic applications. View Full-Text
Share & Cite This Article
Tukun, F.-L.; Olberg, D.E.; Riss, P.J.; Haraldsen, I.; Kaass, A.; Klaveness, J. Recent Development of Non-Peptide GnRH Antagonists. Molecules 2017, 22, 2188.
Tukun F-L, Olberg DE, Riss PJ, Haraldsen I, Kaass A, Klaveness J. Recent Development of Non-Peptide GnRH Antagonists. Molecules. 2017; 22(12):2188.Chicago/Turabian Style
Tukun, Feng-Ling; Olberg, Dag E.; Riss, Patrick J.; Haraldsen, Ira; Kaass, Anita; Klaveness, Jo. 2017. "Recent Development of Non-Peptide GnRH Antagonists." Molecules 22, no. 12: 2188.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.